SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹44 Cr | ₹46 Cr | ₹28 Cr | ₹23 Cr | ₹19 Cr |
What is the latest Total Current Liabilities ratio of SOTAC PHARMACEUTICALS ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹44 Cr |
Mar2023 | ₹46 Cr |
Mar2022 | ₹28 Cr |
Mar2021 | ₹23 Cr |
Mar2020 | ₹19 Cr |
How is Total Current Liabilities of SOTAC PHARMACEUTICALS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹44 Cr | -4.54 | |
Mar2023 | ₹46 Cr | 65.96 | |
Mar2022 | ₹28 Cr | 21.27 | |
Mar2021 | ₹23 Cr | 17.69 | |
Mar2020 | ₹19 Cr | - |
Compare Total Current Liabilities of peers of SOTAC PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SOTAC PHARMACEUTICALS | ₹119.9 Cr | -2.7% | -13.9% | -19.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,936.0 Cr | -5.8% | -3.2% | 35.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,157.0 Cr | -2.8% | -3.6% | 44.7% | Stock Analytics | |
CIPLA | ₹116,200.0 Cr | -3.9% | -0.5% | 13.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹111,325.0 Cr | -1.2% | 7.1% | 17.8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹98,037.4 Cr | -2.7% | -0.1% | 40.9% | Stock Analytics |
SOTAC PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SOTAC PHARMACEUTICALS | -2.7% |
-13.9% |
-19.6% |
SENSEX | -2.1% |
-6.4% |
7% |
You may also like the below Video Courses